Market closed·Syncing…
SMEMarket closed · Close · 19 Nov

Nidan Laboratories and Healthcare Limited NIDANshare price and chart

Nidan Laboratories and Healthcare closed at ₹12.60 on 19 November 2026, down 4.55% on the day. The 52-week range is ₹11.50 to ₹24.90.

₹12.60The price one share last traded at, in rupees.▼ 4.55% · ₹0.60
52-wk low ₹128% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹25

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on NIDAN

Real prices, every charge counted. Pick one or write your own.
What Nidan Laboratories and Healthcare Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Nidan Laboratories and Healthcare provides diagnostic services under one roof, including pathology, radiology, cardiology and neurology, and has operated for about 30 years.

1
1Sector

Healthcare Services

2
2What it sells

Pathology, radiology, cardiology and neurology diagnostics

3
3Who buys it

Patients

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
46.1Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
100%Near average
today 100%20d avg 89%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 4.4%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 13.5%1 monthHow much the share price has changed over the period.▼ 6.0%3 monthsHow much the share price has changed over the period.▼ 8.7%1 yearHow much the share price has changed over the period.▼ 31.5%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.59.9%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹18 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.14.8xlast 4 quarters, to Sept 2026Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.0.25xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.5.5%full year FY26Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.17xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.4.7%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Healthcare Service Provider · 15 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.14.82vs 45.25 median
Cheapest: ONEGLOBAL 11.99Priciest: VIJAYA 76.29
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.4.77%vs 14.05% median
Lowest: HEALTHX -1.41%Highest: 3BBLACKBIO 35.36%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.-8.41%vs 25.84% median
Lowest: ONEGLOBAL -50.77%Highest: HEALTHX 60.66%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules
Worth watching
  • Promoter holding fell 5.8 points over 12 quarters (62.79% to 57.04%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
-33.4%a year, over 5 years
1 yr
-37.0%
3 yr
-29.3%
5 yr
-33.4%

Held for 5 years this compounded at -33.4% a year. The last twelve months were down -37.0%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
57.04%promoter holding, as of 2026-09-30-14.2 pts since 2021
Promoter share since listing
2021-1157.04% now, drawn to its own range2026-09

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Copy of Newspaper Publication06-Nov-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Outcome of Board Meeting05-Nov-2026

Nidan Laboratories And Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201814-Oct-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter05-Oct-2026

Nidan Laboratories And Healthcare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__

Shareholders meeting28-Sep-2026

Nidan Laboratories And Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.

Shareholders meeting28-Sep-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026

Trading Window25-Sep-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Copy of Newspaper Publication03-Sep-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Shareholders meeting02-Sep-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Notice of undefined to be held on September 28, 2026

Updates20-Aug-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding 'Book Closure'.

Outcome of Board Meeting20-Aug-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201814-Jul-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter09-Jul-2026

Nidan Laboratories And Healthcare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 1 FY 2026-27

Copy of Newspaper Publication26-May-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Change in Management25-May-2026

Nidan Laboratories And Healthcare Limited has informed the Exchange about change in Management

Backtest idea · NIDANMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDANLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDANSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on NIDAN
Your own ideaWrite a rule for NIDAN in plain English“Buy NIDAN when …”
Start writing
Buy the dip on NIDANBuy when RSI(14) drops below 30
52-week high breakout on NIDANBuy when closes at a 52-week high
Golden cross on NIDANBuy when 50-day EMA crosses above 200-day
Stochastic oversold on NIDANBuy when stochastic %K drops below 20
Pullback in an uptrend on NIDANBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹18 cr
Larger than 0% of 15 peers
sector middle ₹1,130 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
14.8x
Lower than 90% of 10 peers
sector middle 45.3x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
0.3x
Lowest of 13 peers
sector middle 5.4x
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
5.5%
Lowest of 9 peers
sector middle 22.4%
FY25 6.2%FY26 5.5%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.17
Higher than 77% of 13 peers
sector middle 0.03
FY25 0.16FY26 0.16
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 53% of 15 peers
sector middle 0.1%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
-8.4%
Lower than 89% of 9 peers
sector middle +25.8%

Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash rose by ₹0 Cr, after ₹0 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹2 Cr
Investing+₹0 Cr
Lenders and shareholders-₹2 Cr
Net change in cash+₹0 Cr

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.6.2%5.5%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.16x0.16x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · NIDANStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDANPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDANBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDAN52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on NIDAN
Backtest idea · NIDANGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on NIDAN
MACD momentum on NIDANBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on NIDANBuy when closes below the lower Bollinger band
Supertrend rider on NIDANBuy when supertrend turns up
Buy the dip on NIDANBuy when RSI(14) drops below 30
52-week high breakout on NIDANBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Healthcare Service Provider
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
LALPATHLAB
Dr. Lal Path Labs Ltd.
32,952 cr56.2x12.0x21.5%29.1%0.0019.4%+19.6%0.89%
VIJAYA
Vijaya Diagnostic Centre Limited
15,559 cr76.3x14.7x19.7%30.3%0.0022.4%+26.7%0.13%
METROPOLIS
Metropolis Healthcare Limited
11,587 cr51.6x7.1x13.4%19.6%0.0112.7%+15.8%0.36%
THYROCARE
Thyrocare Technologies Limited
8,035 cr56.1x14.5x28.7%37.8%0.0015.4%+25.1%1.39%
NEPHROPLUS
Nephrocare Health Services Limited
6,455 cr49.4x5.4x6.9%13.4%0.0711.5%-0.00%
SURAKSHA
Suraksha Diagnostic Limited
1,718 cr41.1x6.2x13.8%24.8%0.0211.9%+25.8%0.15%
KRSNAA
Krsnaa Diagnostics Limited
1,673 cr17.0x1.6x10.9%12.7%0.5711.1%+31.5%0.39%
3BBLACKBIO
3B Blackbio Dx Limited
1,130 cr19.1x----35.4%+42.4%0.38%
HEALTHX
Health X Platform Limited
867 cr-1.4x-0.2%-0.04-1.4%+60.7%0.00%
CREDENT
Credent Connect N Care Limited
860 cr-6.1x--0.15--0.00%
ONEGLOBAL
One Global Service Provider Limited
749 cr12.0x----14.1%-50.8%0.26%
GAUDIUMIVF
Gaudium IVF and Women Health Limited
724 cr28.7x4.4x16.1%20.4%0.0320.8%-0.00%
CHANDAN
Chandan Healthcare Limited
599 cr-3.5x-22.4%0.32--0.00%
PRAMODINI
Pramodini Medicare Limited
230 cr-2.0x--0.26--0.00%
INVICTA
Invicta Diagnostic Limited
97 cr-1.7x--0.02--0.00%
NIDAN
Nidan Laboratories and Healthcare Limited
18 cr14.8x0.3x-5.5%0.174.8%-8.4%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-18.2
+5.6
-20.8
+18.0
-3.3
-10.0
+2.7
-1.9
-4.9
+3.6
-3.1
·
-32.4%
11m
2025
-14.4
-16.8
-19.5
+20.9
+5.0
+1.7
-4.0
-11.7
+0.8
+1.9
+22.6
-18.2
-35.3%
2024
+10.4
-8.2
-19.9
+8.3
+15.5
+9.8
-5.5
-5.3
-0.9
-8.8
-4.7
+0.7
-13.3%
2023
+3.8
-12.0
-23.1
+23.6
+3.7
+1.4
-4.7
-9.3
-18.4
+1.1
+6.5
-0.5
-30.9%
2022
-1.6
-19.0
-19.2
+23.5
-9.9
-6.6
-4.6
+42.3
+29.9
-10.5
-1.5
-10.2
-6.6%
2021
·
·
·
·
·
·
·
·
·
·
·
-14.5
-14.5%
1m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2025-11-28VAGHANI VIRAJ · bulkBUY80,000₹21.98₹0.18 Cr
2025-03-07SATYA PRAKASH MITTAL · bulkSELL89,000₹21.65₹0.19 Cr
2025-03-07NEELAM MITTAL · bulkBUY89,000₹21.65₹0.19 Cr
2024-07-01MITTAL PUNEET · bulkBUY87,000₹37.95₹0.33 Cr
2024-07-01MITTAL PUNEET · bulkSELL87,000₹37.84₹0.33 Cr
2024-06-28MITTAL PUNEET · bulkSELL1,92,000₹37.64₹0.72 Cr
2024-06-28MITTAL PUNEET · bulkBUY1,92,000₹37.29₹0.72 Cr
2024-06-24MITTAL PUNEET · bulkBUY87,000₹33.67₹0.29 Cr

Read enough? Test NIDAN. “Buy NIDAN when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free